5th ALS Drug Development Summit 2026

 

Uniting 100+ key ALS and FTD stakeholders across pharma, biotech, academia, patient and caregiver communities, key research funding organizations and advocacy groups, the 5th ALS Drug Development Summit is the ultimate platform honing industry R&D for safer, more effect and patient-relevant drugs that serve the community, driving a cure for sporadic and familial ALS.

With 30+ expert speakers and a program spanning early target exploration through to clinical design, biomarker strategy, and regulatory engagement, attendees will gain comprehensive insights into genetically validated targets, the evolving biology of TDP 43, adaptive trial design, and embedding the patient voice throughout development.

Date: June 2-4, 2026

Location: Boston, MA

More Info

---

---